Urist Marshallinsider trades

In SEC Form 4 filings, Urist Marshall is listed as EVP, Research & Investments of Royalty Pharma plc (RPRX). In the last 90 days, Urist Marshall sold $474.4K of Royalty Pharma plc (RPRX) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
RPRXRoyalty Pharma plc	EVP, Research & Investments	2	Oct 5

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-30

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RPRXRoyalty Pharma plc	Oct 5	Oct 5	S	4,126	$57.10	Sale −$235,595	not reported	Yes	Form 4
RPRXRoyalty Pharma plc	Sep 28	Sep 30	S	4,126	$57.88	Sale −$238,813	4,126	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.